Cerenome, Inc.(CNSY)

Medical - Pharmaceuticals · Houston, TX

$1.58+0.02 (+1.32%)

Delayed quote: Oct 6, 2026, 1:03 PM EDT

Operating Cash Flow Yield: N/A

Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The operating cash flow yield is N/A as of 2026-10-06T17:06:20.491Z.

Stored calculation inputs

Calculation as of: 2026-10-06T17:06:20.491Z.

Quote observation: 2026-10-06T17:03:42.000Z. Amounts in USD. The price header may show a later quote.

TTM operating cash flow · period ending 2026-06-30: -22,175,000
Quote market capitalization: 10,879,444

FMP input reference: 7e5dd7cae71be814523bfc9444594aa14e5919ebae0d9bfc7936539f469f7652

P/OCF Ratio|FCF Yield|Earnings Yield|EBITDA Yield|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

CNSY Operating Cash Flow Yield Metrics

OPERATING CASH FLOW YIELD

N/A

CNSY Competitors' Operating Cash Flow Yield

CNSY

Cerenome, Inc.

Current

Market Cap

$10.88M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CABR

Caring Brands, Inc.

vs CNSY

Market Cap

$10.96M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ADIL

Adial Pharmaceuticals, Inc.

vs CNSY

Market Cap

$11.24M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

KPRX

Kiora Pharmaceuticals, Inc.

vs CNSY

Market Cap

$11.12M

Operating Cash Flow Yield

N/A

TTM Avg

42.53%

3Y Avg

42.53%

5Y Avg

42.53%

BIVI

BioVie Inc.

vs CNSY

Market Cap

$11.12M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LSTA

Lisata Therapeutics, Inc.

vs CNSY

Market Cap

$10.65M

Operating Cash Flow Yield

N/A

TTM Avg

28.18%

3Y Avg

28.18%

5Y Avg

28.18%

PLUR

Pluri Inc.

vs CNSY

Market Cap

$11.11M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LFWD

Lifeward Ltd.

vs CNSY

Market Cap

$10.63M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GDTC

CytoMed Therapeutics Limited

vs CNSY

Market Cap

$10.51M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BFRI

Biofrontera Inc.

vs CNSY

Market Cap

$11.39M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	OPERATING CASH FLOW YIELD	TTM	3Y	5Y
Cerenome, Inc. (CNSY)	$10.88M	N/A	N/A	N/A	N/A
Caring Brands, Inc. (CABR)vs ›	$10.96M	N/A	N/A	N/A	N/A
Adial Pharmaceuticals, Inc. (ADIL)vs ›	$11.24M	N/A	N/A	N/A	N/A
Kiora Pharmaceuticals, Inc. (KPRX)vs ›	$11.12M	N/A	42.53%	42.53%	42.53%
BioVie Inc. (BIVI)vs ›	$11.12M	N/A	N/A	N/A	N/A
Lisata Therapeutics, Inc. (LSTA)vs ›	$10.65M	N/A	28.18%	28.18%	28.18%
Pluri Inc. (PLUR)vs ›	$11.11M	N/A	N/A	N/A	N/A
Lifeward Ltd. (LFWD)vs ›	$10.63M	N/A	N/A	N/A	N/A
CytoMed Therapeutics Limited (GDTC)vs ›	$10.51M	N/A	N/A	N/A	N/A
Biofrontera Inc. (BFRI)vs ›	$11.39M	N/A	N/A	N/A	N/A

Operating Cash Flow Yield Formula & Definition

OCF Yield = TTM Operating Cash Flow / Market Cap

Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Operating Cash Flow Yield: N/A

CNSY Operating Cash Flow Yield Metrics

CNSY Competitors' Operating Cash Flow Yield

Operating Cash Flow Yield Formula & Definition

Related Metrics